These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 6698334

  • 1. [Results of the surgical treatment of pancreatic cancer. Study of a series of 96 surgically treated patients].
    Moreaux J, Catala M, Marzano L.
    Gastroenterol Clin Biol; 1984 Jan; 8(1):11-6. PubMed ID: 6698334
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Regional pancreatectomy in the treatment of pancreatic adenocarcinoma. Apropos of 41 cases].
    Solassol C, Joyeux H, Yakoun M, Blanc F, Bories P.
    Gastroenterol Clin Biol; 1984 Jan; 8(1):17-21. PubMed ID: 6698335
    [Abstract] [Full Text] [Related]

  • 4. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
    Ridwelski K, Meyer F, Schmidt U, Lippert H.
    Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The role of paraaortic lymph node involvement on early recurrence and survival after macroscopic curative resection with extended lymphadenectomy for pancreatic carcinoma.
    Shimada K, Sakamoto Y, Sano T, Kosuge T.
    J Am Coll Surg; 2006 Sep; 203(3):345-52. PubMed ID: 16931307
    [Abstract] [Full Text] [Related]

  • 7. Surgery for mucin-producing pancreatic tumor.
    Yasuda H, Takada T, Amano H, Yoshida M.
    Hepatogastroenterology; 1998 Sep; 45(24):2009-15. PubMed ID: 9951855
    [Abstract] [Full Text] [Related]

  • 8. Pancreatic carcinoma: reappraisal of surgical experiences in one Japanese university hospital.
    Yamaguchi K, Shimizu S, Yokohata K, Noshiro H, Chijiiwa K, Tanaka M.
    Hepatogastroenterology; 1999 Sep; 46(30):3257-62. PubMed ID: 10626197
    [Abstract] [Full Text] [Related]

  • 9. Significance of lymph node metastases in patients with pancreatic cancer undergoing curative resection.
    Delcore R, Rodriguez FJ, Forster J, Hermreck AS, Thomas JH.
    Am J Surg; 1996 Nov; 172(5):463-8; discussion 468-9. PubMed ID: 8942545
    [Abstract] [Full Text] [Related]

  • 10. Distal pancreatectomy--does it have a role for pancreatic body and tail cancer.
    Kayahara M, Nagakawa T, Ueno K, Ohta T, Kitagawa H, Arakawa H, Yagi H, Tajima H, Miwa K.
    Hepatogastroenterology; 1998 Nov; 45(21):827-32. PubMed ID: 9684142
    [Abstract] [Full Text] [Related]

  • 11. [Is resection of left-sided ductal pancreatic carcinoma of value?]].
    Gebhardt C, Meyer W, Jurowich C.
    Zentralbl Chir; 2000 Nov; 125(12):966-9. PubMed ID: 11190614
    [Abstract] [Full Text] [Related]

  • 12. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival.
    Massucco P, Capussotti L, Magnino A, Sperti E, Gatti M, Muratore A, Sgotto E, Gabriele P, Aglietta M.
    Ann Surg Oncol; 2006 Sep; 13(9):1201-8. PubMed ID: 16955382
    [Abstract] [Full Text] [Related]

  • 13. Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified?
    Gleisner AL, Assumpcao L, Cameron JL, Wolfgang CL, Choti MA, Herman JM, Schulick RD, Pawlik TM.
    Cancer; 2007 Dec 01; 110(11):2484-92. PubMed ID: 17941009
    [Abstract] [Full Text] [Related]

  • 14. EIPL (extensive intraoperative peritoneal lavage) therapy significantly reduces peritoneal recurrence after pancreatectomy in patients with pancreatic cancer.
    Yamamoto K, Shimada S, Hirota M, Yagi Y, Matsuda M, Baba H.
    Int J Oncol; 2005 Nov 01; 27(5):1321-8. PubMed ID: 16211228
    [Abstract] [Full Text] [Related]

  • 15. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.
    Cleary SP, Gryfe R, Guindi M, Greig P, Smith L, Mackenzie R, Strasberg S, Hanna S, Taylor B, Langer B, Gallinger S.
    J Am Coll Surg; 2004 May 01; 198(5):722-31. PubMed ID: 15110805
    [Abstract] [Full Text] [Related]

  • 16. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma.
    Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Büchler MW.
    Br J Surg; 2004 May 01; 91(5):586-94. PubMed ID: 15122610
    [Abstract] [Full Text] [Related]

  • 17. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA, Kivlen M, Li M, Schneider D, Chuter T, Jensen RT.
    Arch Surg; 2003 Aug 01; 138(8):859-66. PubMed ID: 12912744
    [Abstract] [Full Text] [Related]

  • 18. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.
    Slidell MB, Chang DC, Cameron JL, Wolfgang C, Herman JM, Schulick RD, Choti MA, Pawlik TM.
    Ann Surg Oncol; 2008 Jan 01; 15(1):165-74. PubMed ID: 17896141
    [Abstract] [Full Text] [Related]

  • 19. Pancreatic resection for M1 pancreatic ductal adenocarcinoma.
    Shrikhande SV, Kleeff J, Reiser C, Weitz J, Hinz U, Esposito I, Schmidt J, Friess H, Büchler MW.
    Ann Surg Oncol; 2007 Jan 01; 14(1):118-27. PubMed ID: 17066229
    [Abstract] [Full Text] [Related]

  • 20. Extended lymphadenectomy in cephalic pancreatoduodenectomy. Personal observations.
    Meriggi F, Gramigna P, Forni E.
    Hepatogastroenterology; 2007 Mar 01; 54(74):549-55. PubMed ID: 17523320
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.